Onconetix, Inc. Current Liabilities
Onconetix, Inc. (ONCO) had Current Liabilities of $2.94 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $2.94M.
- 2026-03-31: Liabilities, Current $3.07M.
- 2025-12-31: Liabilities, Current $9.14M.
- 2025-09-30: Liabilities, Current $16.30M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $2.94M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $3.07M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $9.14M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $16.30M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $12.69M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $14.04M 10-Q · filed 2025-06-12 |
| 2024-12-31 | $18.29M 10-K · filed 2026-03-13 |
| 2024-09-30 | $17.36M 10-Q · filed 2024-12-10 |
| 2024-06-30 | $20.60M 10-Q · filed 2024-08-29 |
| 2024-03-31 | $21.43M 10-Q · filed 2024-05-20 |
| 2023-12-31 | $17.19M 10-K · filed 2025-06-02 |
| 2023-09-30 | $17.65M 10-Q · filed 2023-11-17 |
| 2023-06-30 | $12.13M 10-Q · filed 2023-10-20 |
| 2023-03-31 | $2.81M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $3.92M 10-K · filed 2024-04-11 |
| 2022-09-30 | $4.43M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $3.06M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $2.80M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $1.64M 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |